Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – US
$599.00
Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – US
$599.00
An interview with a US key opinion leader (KOL) on seasonal influenza vaccination coverage rates and trends in main risk groups, key marketed vaccines, pipeline approaches, and the potential for a universal influenza vaccine
SKU: N/A
Author: Datamonitor Healthcare
Publisher: Biomedtracker
Published: 19 November 2018
Number of pages:14
Formats:PDF
Report code:TL #10140
Highlights
Description
Highlights
“I think the CDC has done a good campaign in terms of marketing to people to get their influenza vaccines, to debunk myths around influenza vaccination. There are patients who hardcore believe that you get the flu from the flu vaccine, and therefore refuse to get vaccinated, then there are patients who just refuse to accept any vaccine.”
“I think people have become more accepting of influenza vaccination over the past 5–10 years, a lot of that I think stems from healthcare workers, and I can explain that, but for most of the US at this point, hospital and nursing homes mandate influenza vaccinations for employees who have patient contact, so that alone has really increased the rates of vaccination in healthcare workers over the past five years in particular.”
Drug Coverage
Fluad
Fluzone High dose
FluMist Quadrivalent
Flublok
Flucelvax
Universal flu vaccines
Overview
An interview with a US key opinion leader (KOL) on seasonal influenza vaccination coverage rates and trends in main risk groups, key marketed vaccines, pipeline approaches, and the potential for a universal influenza vaccine
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726
informa
Call Back
We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.OkRead more